International Dermatology Research

Montreal, Quebec H4A 3J1

0 studies enrolling now · 4 studies all time

What they study most

Atopic Dermatitis, Plaque Psoriasis, Psoriasis

Studies at this site

• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis. — Completed
• Long-Term Follow-Up Study of Psoriasis Patients — Completed
• A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis — Completed